Global Pet DNA Vaccines Market Research Report 2024

Publication ID:

PB504241902

Publication Date:

April 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

DNA vaccines are the direct application of antigen-encoding DNA vectors.
Introduce into the body, express the protein, and then pass through the cells and body fluids
The immune response to produce antibodies, to achieve a method of prevention and treatment of disease.
The global Pet DNA Vaccines market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 107.2 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 377%.
This report aims to provide a comprehensive presentation of the global market for Pet DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet DNA Vaccines.
Report Scope
The Pet DNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet DNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet DNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Pfizer
Ringpu
Segment by Type
Rabies Vaccine
Others
Segment by Application
Dog
Cat
Dird
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Pet DNA Vaccines Market Overview
1.1 Product Overview and Scope of Pet DNA Vaccines
1.2 Pet DNA Vaccines Segment by Type
1.2.1 Global Pet DNA Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Rabies Vaccine
1.2.3 Others
1.3 Pet DNA Vaccines Segment by Application
1.3.1 Global Pet DNA Vaccines Market Value by Application: (2024-2030)
1.3.2 Dog
1.3.3 Cat
1.3.4 Dird
1.3.5 Others
1.4 Global Pet DNA Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pet DNA Vaccines Revenue 2019-2030
1.4.2 Global Pet DNA Vaccines Sales 2019-2030
1.4.3 Global Pet DNA Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pet DNA Vaccines Market Competition by Manufacturers
2.1 Global Pet DNA Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pet DNA Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pet DNA Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Pet DNA Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet DNA Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet DNA Vaccines, Product Type & Application
2.7 Pet DNA Vaccines Market Competitive Situation and Trends
2.7.1 Pet DNA Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet DNA Vaccines Players Market Share by Revenue
2.7.3 Global Pet DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet DNA Vaccines Retrospective Market Scenario by Region
3.1 Global Pet DNA Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pet DNA Vaccines Global Pet DNA Vaccines Sales by Region: 2019-2030
3.2.1 Global Pet DNA Vaccines Sales by Region: 2019-2024
3.2.2 Global Pet DNA Vaccines Sales by Region: 2025-2030
3.3 Global Pet DNA Vaccines Global Pet DNA Vaccines Revenue by Region: 2019-2030
3.3.1 Global Pet DNA Vaccines Revenue by Region: 2019-2024
3.3.2 Global Pet DNA Vaccines Revenue by Region: 2025-2030
3.4 North America Pet DNA Vaccines Market Facts & Figures by Country
3.4.1 North America Pet DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pet DNA Vaccines Sales by Country (2019-2030)
3.4.3 North America Pet DNA Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet DNA Vaccines Market Facts & Figures by Country
3.5.1 Europe Pet DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pet DNA Vaccines Sales by Country (2019-2030)
3.5.3 Europe Pet DNA Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet DNA Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Pet DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pet DNA Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Pet DNA Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pet DNA Vaccines Market Facts & Figures by Country
3.7.1 Latin America Pet DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pet DNA Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Pet DNA Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet DNA Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pet DNA Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pet DNA Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet DNA Vaccines Sales by Type (2019-2030)
4.1.1 Global Pet DNA Vaccines Sales by Type (2019-2024)
4.1.2 Global Pet DNA Vaccines Sales by Type (2025-2030)
4.1.3 Global Pet DNA Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Pet DNA Vaccines Revenue by Type (2019-2030)
4.2.1 Global Pet DNA Vaccines Revenue by Type (2019-2024)
4.2.2 Global Pet DNA Vaccines Revenue by Type (2025-2030)
4.2.3 Global Pet DNA Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Pet DNA Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pet DNA Vaccines Sales by Application (2019-2030)
5.1.1 Global Pet DNA Vaccines Sales by Application (2019-2024)
5.1.2 Global Pet DNA Vaccines Sales by Application (2025-2030)
5.1.3 Global Pet DNA Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Pet DNA Vaccines Revenue by Application (2019-2030)
5.2.1 Global Pet DNA Vaccines Revenue by Application (2019-2024)
5.2.2 Global Pet DNA Vaccines Revenue by Application (2025-2030)
5.2.3 Global Pet DNA Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Pet DNA Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer Healthcare
6.1.1 Bayer Healthcare Corporation Information
6.1.2 Bayer Healthcare Description and Business Overview
6.1.3 Bayer Healthcare Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Healthcare Pet DNA Vaccines Product Portfolio
6.1.5 Bayer Healthcare Recent Developments/Updates
6.2 Vetoquinol S.A
6.2.1 Vetoquinol S.A Corporation Information
6.2.2 Vetoquinol S.A Description and Business Overview
6.2.3 Vetoquinol S.A Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Vetoquinol S.A Pet DNA Vaccines Product Portfolio
6.2.5 Vetoquinol S.A Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Pet DNA Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Pet DNA Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eli Lilly Pet DNA Vaccines Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Heska
6.6.1 Heska Corporation Information
6.6.2 Heska Description and Business Overview
6.6.3 Heska Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Heska Pet DNA Vaccines Product Portfolio
6.6.5 Heska Recent Developments/Updates
6.7 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Animal Health Pet DNA Vaccines Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 Merial (Sanofi)
6.8.1 Merial (Sanofi) Corporation Information
6.8.2 Merial (Sanofi) Description and Business Overview
6.8.3 Merial (Sanofi) Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merial (Sanofi) Pet DNA Vaccines Product Portfolio
6.8.5 Merial (Sanofi) Recent Developments/Updates
6.9 Virbac
6.9.1 Virbac Corporation Information
6.9.2 Virbac Description and Business Overview
6.9.3 Virbac Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Virbac Pet DNA Vaccines Product Portfolio
6.9.5 Virbac Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfizer Pet DNA Vaccines Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Ringpu
6.11.1 Ringpu Corporation Information
6.11.2 Ringpu Pet DNA Vaccines Description and Business Overview
6.11.3 Ringpu Pet DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Ringpu Pet DNA Vaccines Product Portfolio
6.11.5 Ringpu Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet DNA Vaccines Industry Chain Analysis
7.2 Pet DNA Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet DNA Vaccines Production Mode & Process
7.4 Pet DNA Vaccines Sales and Marketing
7.4.1 Pet DNA Vaccines Sales Channels
7.4.2 Pet DNA Vaccines Distributors
7.5 Pet DNA Vaccines Customers
8 Pet DNA Vaccines Market Dynamics
8.1 Pet DNA Vaccines Industry Trends
8.2 Pet DNA Vaccines Market Drivers
8.3 Pet DNA Vaccines Market Challenges
8.4 Pet DNA Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Pfizer
Ringpu

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂